(S)-4-BENZYL-2-(PYRAZIN-2-YL)-4,5-DIHYDROOXAZOLE, 95%, 100mg

(3'-Methyl-[1,1'-biphenyl]-4-yl)methanamine hydrochloride, 95%, 1g

Methyl 4-formyl-3-nitrobenzoate, 95.0%, 5g

4-Dodecyloxyphthalonitrile>99.0%(GC)1g

(3aR,6R,6aR)-2,2,6-Trimethyl-6-vinyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-one, 98%, 500mg

((4-(2-Methoxyphenoxy)phenyl)sulfonyl)glycine, 97%, 100mg

4-(2-Oxo-pyrrolidin-1-yl)-benzenesulfonyl chloride, 95.0%, 1g

(1R,5R)-9-Tosyl-9-azabicyclo[3.3.1]nona-2,6-diene, 95.0%, 250mg

3-Bromophenylmethylsulfone, 98.0%, 1g

2-(2,3-dihydro-1H-indol-1-yl)ethanamine, 95.0%, 5g

4-BROMOMETHYL-2-CHLOROQUINOLINE, 97.0%, 1g

Matraces de fondo redondo de tres bocas con cuellos laterales paralelos, 4000 ml, 29/32, 29/32, 1 unidad

(BENZO[B]THIOPHEN-7-YL)METHANAMINE HCL, 95.0%, 250mg